Examiner: CARCANAGUE, DANIEL R

Tech Center 1600 • Art Units: 1621 1625

This examiner grants 81% of resolved cases

Performance Statistics

80.8%

Allow Rate

+20.8% vs TC avg

935

Total Applications

+24.5%

Interview Lift

617

Avg Prosecution Days

Based on 931 resolved cases, 2023–2026

0.5%

§101 Eligibility

15.8%

§102 Novelty

30.9%

§103 Obviousness

16.0%

§112 Clarity

App #	Title	Status	Assignee
18746981	PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS	Non-Final OA	Xenon Pharmaceuticals Inc.
18196255	NOVEL ACRIDINIUM SALT AND METHOD FOR PRODUCING SAME	Non-Final OA	SHIONOGI PHARMA CO., LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.